Keyphrases
Caenorhabditis Elegans
57%
Healthspan
57%
Visfatin
57%
Omental
57%
In Vitro Expansion
57%
Abdominal Adipose Tissue
57%
Liver
57%
Aging State
57%
Understanding of Cancer
57%
Nutritional Deficiency
57%
Diabetic Patients
57%
Obese Patients
57%
Adipocyte
57%
Cell Culture
57%
Evolutionary Biology
57%
Flow Cytometric Analysis
57%
Knockdown
57%
DAF-16
47%
Male Donor
38%
Liver Cells
38%
Darwinian
28%
Future Therapeutics
28%
Genetic Drift
28%
Natural Selection
28%
Obesity
28%
Lymphocytes
28%
Clinical Observation
28%
Cardiovascular Morbidity
28%
High Prevalence
28%
Type 2 Diabetes Mellitus (T2DM)
28%
Environmental Factors
28%
Cardiovascular Mortality
28%
High Blood Pressure
28%
Type 1 Diabetes Mellitus (T1DM)
28%
Medical Oncologist
28%
Developed Countries
28%
Public Health Risk
28%
Amino Acids
28%
High Incidence
28%
Genetic Components
28%
Therapeutic Approaches
28%
Fat Depots
19%
Characteristic Markers
19%
Epithelial-to-mesenchymal Transition
19%
Cell Propagation
19%
Marker Expression
19%
Loss of Chromosome Y
19%
Cell Stability
19%
Molecular Changes
19%
Background Liver
19%
Biochemistry, Genetics and Molecular Biology
Transdifferentiation
100%
Caenorhabditis Elegans
57%
DNA Demethylation
57%
Metabolic Pathway
57%
Lifespan
57%
Y Chromosome
57%
Cell Culture
57%
Adipocyte
57%
Liver Cell Culture
28%
Daf-16
28%
DNA Methylation
28%
Mesenchymal-Epithelial Transition
28%
Adult Stem Cell
19%
Transcription Factors
19%
Wild Type
14%
Cell Proliferation
14%
Lipid Storage
9%
Regulatory Site
9%
Cell Size
9%
DNA Hypomethylation
9%
Body Fat
9%
Epigenetics
9%
Genetic Manipulation
7%
Genetics
7%
Aging
7%
Gene Inactivation
7%
Medicine and Dentistry
Liver Cell
85%
In Vitro
71%
Metabolism
57%
Nicotinamide Phosphoribosyltransferase
57%
Cell Culture
57%
Cell Transdifferentiation
42%
Y Chromosome
28%
Diabetes Mellitus
14%
Cell Replacement Therapy
14%
Mesenchymal-Epithelial Transition
14%
Cell Therapy
14%
Cell Proliferation
14%
Elderly (Age Groups)
14%
Ultrastructure
14%
Drug Therapy
14%
Medicine
14%
Adult Stem Cell
11%